KALV KalVista Pharmaceuticals

Watchlist

Close Apr 26 16:00 ET

Post 16:20 ET

454.79MMarket Cap-3455P/E (TTM)

KalVista Pharmaceuticals Stock Analyst Ratings & Price Target

Updated: Apr 28, 2024

Based on 4 analysts giving stock ratings to KalVista Pharmaceuticals in the past 3 months

Strong Buy

Updated: Apr 28, 2024

The average KalVista Pharmaceuticals stock price target is 32.67 with a max estimate of 39.00 and a min estimate of 24.00

Review KalVista Pharmaceuticals earnings estimates

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Updated: Apr 28, 2024

Strong Buy

Updated: Apr 28, 2024

Overall